Although quality of care in NA-ACCORD cohorts was significantly better than the national average, disparities remained, with women, young adults, blacks, and injection-drug users faring worse than other groups.
Using DHHS-approved indicators for monitoring the quality of HIV care (retention in care, antiretroviral therapy [ART] use, and virologic suppression), investigators from the NA-ACCORD study examined outcomes for their population as well as differences by demographic characteristics and HIV risk groups.
NA-ACCORD, a multisite collaboration of cohort studies involving HIV-infected adults in the U.S. and Canada, includes approximately 3% of adults living with HIV in the U.S. For the present analysis, the investigators looked at U.S. clinical cohorts from 2009. A total of 35,324 patients had ≥1 HIV care visit between January and June 2008 and were included in the retention-in-care analysis; 38,331 of these patients had ≥1 HIV care visit in 2009…
Reviewing Author
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)